Rocket


News + Filings
Transactions





MOTT DAVID M

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
10/02/2023Mersana Therapeutics, Inc.MRSNGrantCommon Stock15.9k$0.00$0 10/02/2023
07/03/2023Mersana Therapeutics, Inc.MRSNGrantCommon Stock6.1k$0.00$0 07/03/2023
07/03/2023Adaptimmune Therapeutics PLCADAPGrantOption to purchase Ordinary Shares1.5M$0.00$0 07/03/2023
06/15/2023ARDELYX, INC.ARDXGrantCommon Stock25.5k$0.00$0 06/15/2023
06/15/2023ARDELYX, INC.ARDXGrantStock Option (Right to Buy)49.2k$3.92$193k 06/15/2023
06/08/2023Mersana Therapeutics, Inc.MRSNGrantStock Option (right to buy)18.4k$8.64$158.6k 06/08/2023
06/08/2023Mersana Therapeutics, Inc.MRSNGrantCommon Stock14.5k$0.00$0 06/08/2023
04/03/2023Mersana Therapeutics, Inc.MRSNGrantCommon Stock4.9k$0.00$0 04/03/2023
11/17/2022ARDELYX, INC.ARDXPurchaseCommon Stock567k$1.76$1M 11/17/2022
08/12/2022Epizyme, Inc.EPZMOtherCommon Stock, par value $0.0001215.5k$0.00$0 08/12/2022
08/12/2022Epizyme, Inc.EPZMDispositionCommon Stock, par value $0.00019k$0.00$0 08/12/2022
08/12/2022Epizyme, Inc.EPZMOtherCommon Stock, par value $0.0001107k$0.00$0See Note08/12/2022
07/01/2022Adaptimmune Therapeutics PLCADAPGrantOption to purchase Ordinary Shares1M$0.00$0 07/01/2022
06/30/2022Epizyme, Inc.EPZMGrantCommon Stock, par value $0.000116.2k$1.47$23.7k 06/30/2022
06/17/2022NOVAVAX INCNVAXExerciseRestricted Stock Units700$0.00$0 06/17/2022
06/15/2022ARDELYX, INC.ARDXGrantCommon Stock182.5k$0.00$0 06/15/2022
06/15/2022ARDELYX, INC.ARDXGrantStock Option (Right to Buy)100k$0.55$54.8k 06/15/2022
06/10/2022NOVAVAX INCNVAXGrantStock Option (Right to Buy)4.6k$40.62$186.9k 06/10/2022
06/10/2022NOVAVAX INCNVAXGrantRestricted Stock Units3.1k$0.00$0 06/10/2022
06/09/2022Mersana Therapeutics, Inc.MRSNGrantStock Option (right to buy)45k$3.62$162.9k 06/09/2022
06/02/2022Enliven Therapeutics, Inc.IMRAGrantStock Options (Right to Buy)8.5k$1.07$9.1k 06/02/2022
05/17/2022Epizyme, Inc.EPZMGrantCommon Stock, par value $0.00019k$0.00$0 05/17/2022
05/17/2022Epizyme, Inc.EPZMGrantStock Option (Right to Buy)41k$0.56$23k 05/17/2022
03/31/2022Epizyme, Inc.EPZMGrantCommon Stock, par value $0.000120.7k$1.15$23.8k 03/31/2022
02/23/2022Enliven Therapeutics, Inc.IMRAPurchaseCommon Stock35.3k$1.46$51.5k 02/18/2022
02/22/2022Enliven Therapeutics, Inc.IMRAPurchaseCommon Stock65.8k$1.56$102.7k 02/18/2022
02/18/2022Enliven Therapeutics, Inc.IMRAPurchaseCommon Stock50.4k$1.30$65.5k 02/18/2022
02/17/2022Enliven Therapeutics, Inc.IMRAPurchaseCommon Stock14.6k$1.17$17.1k 02/15/2022
02/16/2022Enliven Therapeutics, Inc.IMRAPurchaseCommon Stock11.8k$1.20$14.1k 02/15/2022
02/15/2022Enliven Therapeutics, Inc.IMRAPurchaseCommon Stock19.6k$1.20$23.5k 02/15/2022
02/14/2022Enliven Therapeutics, Inc.IMRAPurchaseCommon Stock8.5k$1.18$10k 02/10/2022
02/11/2022Enliven Therapeutics, Inc.IMRAPurchaseCommon Stock14.6k$1.23$17.9k 02/10/2022
02/10/2022Enliven Therapeutics, Inc.IMRAPurchaseCommon Stock8.8k$1.29$11.3k 02/10/2022
01/03/2022Mersana Therapeutics, Inc.MRSNGrantStock Option (right to buy)18.5k$6.44$119.3k 01/03/2022
12/31/2021Epizyme, Inc.EPZMGrantCommon Stock, par value $0.00019.5k$2.50$23.8k 12/31/2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy